Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in GIST Patients on Tyrosine Kinase Inhibitor Therapy: Cognitive Behavioral Therapy to Improve Cognitive Symptoms

NCT04879979 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT04879979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04879979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in GIST Patients on Tyrosine Kinase Inhibitor Therapy: Cognitive Behavioral Therapy to Improve Cognitive Symptoms
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Terminated
Start date
January 12, 2021
Completion date
May 4, 2022
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cbt, gist, malignant